Cancer Research Technology
Log in Register
Menu

Anti-AP2b [AP2bß 1F3/8]

Invented by Helen Hurst
Invented at Queen Mary Innovation Ltd

Info

Catalogue Number 151274
Applications ELISA IHC WB
Antigen/Gene or Protein Targets Activating Protein 2 (AP-2) beta
Reactivity Human
Relevance AP-2 is a family of developmentally regulated transcription factors which also play a role in breast cancer and melanoma. AP-2ß may be important in cardiac and kidney development. The AP-2 transcription factors form the OB2 complex that has been shown to up-regulate c-erb-B2 transcription.
Host Mouse
Immunogen Truncated AP-2ß protein prepared from bacteria
Positive Control Human breast cancer line MDA MB 453
Subclass IgG2a
Molecular Weight (kDa) 50
Myeloma Used Sp2/0-Ag14
Recommended Growing Conditions DMEM + 5% FCS
Strain Balb/c
Notes Antigen recovery using microwave or pressure cooking required for paraffin embedded tissue.
Research Area Cancer, Cardiovascular, Epigenetics & Nuclear Signalling

References

There are 3 reference entries for this reagent.

View All References

References: 3 entries

Personal communication.

Ebauer et al. 2007. Oncogene. 26(51):7267-81. PMID: 17525748.

Comparative expression profiling identifies an in vivo target gene signature with TFAP2B as a mediator of the survival function of PAX3/FKHR.

Europe PMC ID: 17525748


Add a reference

References: 3 entries

Personal communication.

Ebauer et al. 2007. Oncogene. 26(51):7267-81. PMID: 17525748.

Comparative expression profiling identifies an in vivo target gene signature with TFAP2B as a mediator of the survival function of PAX3/FKHR.


Add a reference

Inventor Information